These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24028839)

  • 1. Fas/FasL pathway participates in resolution of mucosal inflammatory response early during HSV-2 infection.
    Krzyzowska M; Baska P; Grochowska A; Orlowski P; Nowak Z; Winnicka A
    Immunobiology; 2014 Jan; 219(1):64-77. PubMed ID: 24028839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway.
    Krzyzowska M; Baska P; Orlowski P; Zdanowski R; Winnicka A; Eriksson K; Stankiewicz W
    PLoS One; 2013; 8(7):e70308. PubMed ID: 23922974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Fas/FasL signaling in regulation of anti-viral response during HSV-2 vaginal infection in mice.
    Krzyzowska M; Orłowski P; Bąska P; Bodera P; Zdanowski R; Stankiewicz W
    Immunobiology; 2014 Dec; 219(12):932-43. PubMed ID: 25129477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Fas/FasL in regulation of inflammation in vaginal tissue during HSV-2 infection.
    Krzyzowska M; Shestakov A; Eriksson K; Chiodi F
    Cell Death Dis; 2011 Mar; 2(3):e132. PubMed ID: 21412278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice.
    Milligan GN; Dudley-McClain KL; Young CG; Chu CF
    J Reprod Immunol; 2004 Apr; 61(2):115-27. PubMed ID: 15063634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus type 2 infection induced apoptosis in peritoneal macrophages independent of Fas and tumor necrosis factor-receptor signaling.
    Fleck M; Mountz JD; Hsu HC; Wu J; Edwards CK; Kern ER
    Viral Immunol; 1999; 12(3):263-75. PubMed ID: 10532654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lack of Fas/FasL signalling leads to disturbances in the antiviral response during ectromelia virus infection.
    Bień K; Sobańska Z; Sokołowska J; Bąska P; Nowak Z; Winnicka A; Krzyzowska M
    Arch Virol; 2016 Apr; 161(4):913-28. PubMed ID: 26780774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sustained type I IFN-neutrophil-IL-18 axis drives pathology during mucosal viral infection.
    Lebratti T; Lim YS; Cofie A; Andhey P; Jiang X; Scott J; Fabbrizi MR; Ozantürk AN; Pham C; Clemens R; Artyomov M; Dinauer M; Shin H
    Elife; 2021 May; 10():. PubMed ID: 34047696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas/FasL pathway participates in regulation of antiviral and inflammatory response during mousepox infection of lungs.
    Bień K; Sokołowska J; Bąska P; Nowak Z; Stankiewicz W; Krzyzowska M
    Mediators Inflamm; 2015; 2015():281613. PubMed ID: 25873756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-inducing FasL on chondrocytes forms immune privilege in cartilage tissue engineering, enhancing in vivo regeneration.
    Fujihara Y; Takato T; Hoshi K
    Stem Cells; 2014 May; 32(5):1208-19. PubMed ID: 24446149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ribonucleotide reductase R1 subunits of herpes simplex virus types 1 and 2 protect cells against TNFα- and FasL-induced apoptosis by interacting with caspase-8.
    Dufour F; Sasseville AM; Chabaud S; Massie B; Siegel RM; Langelier Y
    Apoptosis; 2011 Mar; 16(3):256-71. PubMed ID: 21107701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible nitric oxide synthase and Fas/FasL with C3 expression of mouse retinal pigment epithelial cells in response to stimulation by peroxynitrite and antagonism of puerarin.
    Hao LN; Zhang YQ; Shen YH; Wang ZY; Wang YH
    Chin Med J (Engl); 2011 Aug; 124(16):2522-9. PubMed ID: 21933599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of Fas-FasL signaling in lethal infection with herpes simplex virus type 2 in mice.
    Ishikawa T; Yamada H; Oyamada A; Goshima F; Nishiyama Y; Yoshikai Y
    J Virol; 2009 Nov; 83(22):11777-83. PubMed ID: 19740996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
    Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
    Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms.
    Dobbs ME; Strasser JE; Chu CF; Chalk C; Milligan GN
    J Virol; 2005 Dec; 79(23):14546-54. PubMed ID: 16282454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
    Gill N; Rosenthal KL; Ashkar AA
    J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-36γ Is a Key Regulator of Neutrophil Infiltration in the Vaginal Microenvironment and Limits Neuroinvasion in Genital HSV-2 Infection.
    Gardner JK; Swaims-Kohlmeier A; Herbst-Kralovetz MM
    J Immunol; 2019 Nov; 203(10):2655-2664. PubMed ID: 31578266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of Fas and Fas ligand during mammary gland remodeling.
    Song J; Sapi E; Brown W; Nilsen J; Tartaro K; Kacinski BM; Craft J; Naftolin F; Mor G
    J Clin Invest; 2000 Nov; 106(10):1209-20. PubMed ID: 11086022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
    Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
    Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.